Skip to main content
. 2012 Jun 11;30(21):2670–2677. doi: 10.1200/JCO.2011.38.9429

Fig 2.

Fig 2.

(A) Overall survival (Kaplan-Meier method) in a protocol-specified 2009 clinical cutoff analysis of decitabine and treatment choice (TC) in the intent-to-treat population. (B) Overall survival (Kaplan-Meier method) in an ad hoc mature (2010) analysis of decitabine and TC in the intent-to-treat population.